MKC
42
-9
DNB
20
2
CME
59
3
CA
24
4
IPG
49
2
WMT
60
-2
MAT
58
2
CCI
30
2
O
39
2
TRV
43
-7
MAS
58
-10
MRO
56
10
VLO
30
-6
CTAS
56
-3
CVS
49
2
CMA
42
2
AMAT
52
-2
PDCO
55
11
AZO
48
5
CNP
49
-8
MKC
42
-9
DNB
20
2
CME
59
3
CA
24
4
IPG
49
2
WMT
60
-2
MAT
58
2
CCI
30
2
O
39
2
TRV
43
-7
MAS
58
-10
MRO
56
10
VLO
30
-6
CTAS
56
-3
CVS
49
2
CMA
42
2
AMAT
52
-2
PDCO
55
11
AZO
48
5
CNP
49
-8
Financhill
Back

Dyne Therapeutics 10K Form

Buy
55

DYN
Dyne Therapeutics

Last Price:
23.87
Seasonality Move:
9.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DYN News And Ratings

See the #1 stock for the next 7 days that we like better than DYN

DYN Financial Statistics

Sales & Book Value

Annual Sales: $4.84B
Cash Flow: $-35.09M
Price / Cash Flow: 0
Annual Sales: $1.49
Price / Book: 21.23

Profitability

EPS (TTM): -3.94000
Net Income (TTM): $-235.94M
Gross Margin: $1.91B
Return on Equity: 0%
Return on Assets: 0%

Dyne Therapeutics Earnings Forecast

Key Dyne Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 13 years for DYN is 39.45%.
  • The Selling, General & Administrative Expenses for DYN have been equal to 3.90% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Dyne Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DYN
CUSIP: 26818M
Website: dyne-tx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DYN Technical Analysis vs Fundamental Analysis

Buy
55
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics a Buy or a Sell?

  • Dyne Therapeutics stock is rated a Buy
    The current Dyne Therapeutics [DYN] share price is $23.65. The Score for DYN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.